Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...

Study explores the clinical manifestations, risk factors, and 90-day mortality outcomes in adults hospitalized with RSV or ...

Oct. 18, 2024 – Older people who aren’t sure about whether to get the vaccine for respiratory syncytial virus (RSV) now have a new set of data to help them make up their minds. A large study ...

In truth, we know what it is: those newly sprouted sunspots, hyperpigmentation, and melasma signs are often triggered by hot ...

BUT HOW DO YOU KNOW IF IT’S THE FLU, RSV OR COVID? TO HELP YOU UNDERSTAND THE DIFFERENCE, THIS MORNING WE WELCOME DOCTOR VANESSA WALKER WITH SUTTER HEALTH. THANK YOU SO MUCH FOR BEING HERE.

The RSV vaccine Abrysvo was highly effective against hospital and ED encounters in a large cohort of older adults with comorbidities and immunocompromising conditions.

Rates of SUID per 100,000 live births rose by 10% from 2019 to 2021. A rise in rates of sudden unexpected infant deaths may have been linked to an off-season surge of respiratory syncytial virus ...

RSV vaccines hold the potential to reduce the thousands of hospitalizations and deaths associated with the virus in the US each year. But vaccines are only effective if they get in the arms of the ...

Regardless, there are ways to prevent and treat discoloration by addressing the root cause and seeking the correct treatment.

Dr. Nina Shapiro is a physician writer who dispels health myths. While clinical trials are currently underway to provide RSV vaccines to pregnant women in order to protect their soon-to-be ...

A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% protection against severe illness and/or hospitalization. With U.S ...